Helix Biopharma

Helix Biopharma Corp is a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology to prevent and treat cancer based on its proprietary technology platform, DOS47. DOS47 provides a novel and revolutionary approach to destroying cancer cells by modulating the tumor microenvironment.